REBECCA FOX: Open Payments
NPI 1639351018 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,621 in 302 payments from 24 companies in 2025. Trend: 2023 $104 · 2024 $4,379 · 2025 $6,621
Food & beverage: $6,524Education: $96
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $1,676 |
| Janssen Biotech, Inc. | 29 | $838 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 30 | $524 |
| Aimmune Therapeutics, Inc. | 21 | $457 |
| Lilly USA, LLC | 20 | $409 |
| QOL Medical, LLC | 16 | $397 |
| GENZYME CORPORATION | 18 | $349 |
| Ardelyx, Inc. | 18 | $283 |
| VIVUS LLC | 15 | $266 |
| Madrigal Pharmaceuticals | 15 | $245 |
Products named: TREMFYA, RINVOQ, SKYRIZI, XIFAXAN, DUPIXENT, ZENPEP, OMVOH, Sucraid.
Industry payments across NC — which companies pay providers there.
